Efficacy of Kakkonto in oral immunotherapy for food Allergy : Randomized Controlled Trial
Not Applicable
Completed
- Conditions
- food allergy
- Registration Number
- JPRN-UMIN000025470
- Lead Sponsor
- Toyama University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1.Complication or past history of heart, liver and kidney diseases. 2.Uncontrolled asthma, atopic dermatitis, allergic rhinitis 3.Children who were judged as inappropriate by the study director
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Kakkonto's efficacy in food allergy immunotherapy?
How does Kakkonto combination therapy compare to standard oral immunotherapy for food allergies?
Which biomarkers correlate with successful Kakkonto-based oral immunotherapy outcomes in food allergy patients?
What adverse events are associated with Kakkonto in food allergy treatment and how are they managed?
Are there alternative herbal compounds to Kakkonto for enhancing oral immunotherapy in food allergy management?